- Home
- NXRT vs LENZ Comparison
NXRT vs LENZ Comparison
Compare NXRT & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXRT
- LENZ
- Stock Information
- Founded
- NXRT 2014
- LENZ 2019
- Country
- NXRT United States
- LENZ United States
- Employees
- NXRT N/A
- LENZ N/A
- Industry
- NXRT Real Estate Investment Trusts
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- NXRT Real Estate
- LENZ Health Care
- Exchange
- NXRT Nasdaq
- LENZ Nasdaq
- Market Cap
- NXRT 859.4M
- LENZ 886.0M
- IPO Year
- NXRT N/A
- LENZ 2021
- Fundamental
- Price
- NXRT $31.73
- LENZ $39.36
- Analyst Decision
- NXRT Hold
- LENZ Strong Buy
- Analyst Count
- NXRT 6
- LENZ 5
- Target Price
- NXRT $40.88
- LENZ $47.00
- AVG Volume (30 Days)
- NXRT 175.1K
- LENZ 580.6K
- Earning Date
- NXRT 07-29-2025
- LENZ 07-30-2025
- Dividend Yield
- NXRT 6.56%
- LENZ N/A
- EPS Growth
- NXRT N/A
- LENZ N/A
- EPS
- NXRT N/A
- LENZ N/A
- Revenue
- NXRT $254,446,000.00
- LENZ $5,000,000.00
- Revenue This Year
- NXRT N/A
- LENZ N/A
- Revenue Next Year
- NXRT $5.28
- LENZ $556.26
- P/E Ratio
- NXRT N/A
- LENZ N/A
- Revenue Growth
- NXRT N/A
- LENZ N/A
- 52 Week Low
- NXRT $29.98
- LENZ $16.54
- 52 Week High
- NXRT $48.37
- LENZ $40.95
- Technical
- Relative Strength Index (RSI)
- NXRT 43.88
- LENZ 67.77
- Support Level
- NXRT $30.43
- LENZ $34.88
- Resistance Level
- NXRT $31.54
- LENZ $40.95
- Average True Range (ATR)
- NXRT 0.93
- LENZ 2.81
- MACD
- NXRT -0.07
- LENZ 0.78
- Stochastic Oscillator
- NXRT 41.87
- LENZ 87.92
About NXRT NexPoint Residential Trust Inc.
NexPoint Residential Trust Inc is a real estate investment trust company. Its objectives are to maximize the cash flow and value of properties owned, acquire properties with cash flow growth potential, provide quarterly cash distributions, and achieve long-term capital appreciation for stockholders. The company seeks to achieve these objectives through targeted management and a capex value-add program. It focuses on acquiring multifamily properties in markets with attractive job growth and household formation fundamentals predominantly in the Southeastern and Southwestern United States. The company generates revenue from the rental of multifamily properties.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.